Sohel Md, Islam Md Nurul, Hossain Md Arju, Sultana Tayeba, Dutta Amit, Rahman Md Sohanur, Aktar Suraiya, Islam Khairul, Al Mamun Abdullah
Department of Biochemistry and Molecular Biology, Mawlana Bhashani Science and Technology University, Santosh, Tangail 1902, Bangladesh.
Department of Pharmacy, Mawlana Bhashani Science and Technology University, Santosh, Tangail 1902, Bangladesh.
Int J Breast Cancer. 2022 Feb 17;2022:2599689. doi: 10.1155/2022/2599689. eCollection 2022.
The use of dietary phytochemical rather than conventional therapies to treat numerous cancers is now a well-known approach in medical science. Easily available and less toxic dietary phytochemicals present in plants should be introduced in the list of phytochemical-based treatment areas. Sesamin, a natural phytochemical, may be a promising chemopreventive agent aiming to manage breast cancer. In this study, we discussed the pharmacological properties of sesamin that determine its therapeutics opportunity to be used in breast cancer treatment and other diseases. Sesamin is available in medicinal plants, especially in , and is easily metabolized by the liver. To better understand the antibreast cancer consequence of sesamin, we postulate some putative pathways related to the antibreast cancer mechanism: (1) regulation of estrogen receptor (ER- and ER-) activities, (2) suppressing programmed death-ligand 1 (PD-L1) overexpression, (3) growth factor receptor inhibition, and (4) some tyrosine kinase pathways. Targeting these pathways, sesamin can modulate cell proliferation, cell cycle arrest, cell growth and viability, metastasis, angiogenesis, apoptosis, and oncogene inactivation in various and animal models. Although the actual tumor intrinsic signaling mechanism targeted by sesamin in cancer treatment is still unknown, this review summarized that this phytoestrogen suppressed NF-B, STAT, MAPK, and PIK/AKT signaling pathways and activated some tumor suppressor protein in numerous breast cancer models. Cotreatment with -tocotrienol, conventional drugs, and several drug carriers systems increased the anticancer potentiality of sesamin. Furthermore, sesamin exhibited promising pharmacokinetics properties with less toxicity in the bodies. Overall, the shreds of evidence highlight that sesamin can be a potent candidate to design drugs against breast cancer. So, like other phytochemicals, sesamin can be consumed for better therapeutic advantages due to having the ability to target a plethora of molecular pathways until clinically trialed standard drugs are not available in pharma markets.
使用膳食植物化学物质而非传统疗法来治疗多种癌症,如今在医学领域已是一种广为人知的方法。植物中易于获取且毒性较小的膳食植物化学物质,应被纳入基于植物化学物质的治疗领域清单。芝麻素,一种天然植物化学物质,可能是一种有前景的化学预防剂,旨在用于管理乳腺癌。在本研究中,我们探讨了芝麻素的药理特性,这些特性决定了其在乳腺癌治疗及其他疾病中应用的治疗机会。芝麻素存在于药用植物中,尤其是在[此处原文缺失具体植物名称],且易于被肝脏代谢。为了更好地理解芝麻素的抗乳腺癌作用,我们推测了一些与抗乳腺癌机制相关的假定途径:(1)雌激素受体(ER-α和ER-β)活性的调节,(2)抑制程序性死亡配体1(PD-L1)的过度表达,(3)生长因子受体抑制,以及(4)一些酪氨酸激酶途径。针对这些途径,芝麻素可在各种细胞和动物模型中调节细胞增殖、细胞周期停滞、细胞生长与活力、转移、血管生成、凋亡以及癌基因失活。尽管芝麻素在癌症治疗中实际靶向的肿瘤内在信号机制仍不明确,但本综述总结,这种植物雌激素在众多乳腺癌模型中抑制了NF-κB、STAT、MAPK和PI3K/AKT信号通路,并激活了一些肿瘤抑制蛋白。与γ-生育三烯酚、传统药物以及几种药物载体系统联合使用,可增强芝麻素的抗癌潜力。此外,芝麻素展现出良好的药代动力学特性,在体内毒性较小。总体而言,证据表明芝麻素可能是设计抗乳腺癌药物的有力候选物。所以,与其他植物化学物质一样,由于芝麻素能够靶向众多分子途径,在制药市场尚无临床试用的标准药物时,可食用芝麻素以获得更好的治疗效果。